中国妊娠期与哺乳期乳腺癌临床实践指南(2022版)

2022-01-30 中华医学会外科学分会乳腺外科学组 中国实用外科杂志

妊娠期乳腺癌和哺乳期乳腺癌发生于女性特殊生理时期,诊疗过程需要兼顾母亲疗效和子代安全,是临床处理的难点。

中文标题:

中国妊娠期与哺乳期乳腺癌临床实践指南(2022版)

发布日期:

2022-01-30

简要介绍:

妊娠期乳腺癌(breast cancer in pregnancy,BCP)和哺乳期乳腺癌(postpartum breast cancer,PBC)发生于女性特殊生理时期,诊疗过程需要兼顾母亲疗效和子代安全,是临床处理的难点。随着我国女性生育年龄的增长和生育政策的改变,BCP和PBC受到越来越多关注。

相关资料下载:
[AttachmentFileName(sort=1, fileName=中国妊娠期与哺乳期乳腺癌临床实践指南(2022版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=6b11e1c0023a8eb0, title=中国妊娠期与哺乳期乳腺癌临床实践指南(2022版), enTitle=, guiderFrom=中国实用外科杂志, authorId=0, author=, summary=妊娠期乳腺癌和哺乳期乳腺癌发生于女性特殊生理时期,诊疗过程需要兼顾母亲疗效和子代安全,是临床处理的难点。, cover=https://img.medsci.cn/202229/1644413231607_5579292.png, journalId=0, articlesId=null, associationId=2134, associationName=中华医学会外科学分会乳腺外科学组, associationIntro=中华医学会外科学分会乳腺外科学组 , copyright=0, guiderPublishedTime=Sun Jan 30 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">妊娠期乳腺癌(breast cancer in pregnancy,BCP)和哺乳期乳腺癌(postpartum breast cancer,PBC)发生于女性特殊生理时期,诊疗过程需要兼顾母亲疗效和子代安全,是临床处理的难点。随着我国女性生育年龄的增长和生育政策的改变,BCP和PBC受到越来越多关注。</span></p>, tagList=[TagDto(tagId=285, tagName=乳腺癌), TagDto(tagId=6294, tagName=妊娠期乳腺癌), TagDto(tagId=117297, tagName=妇瘤乳腺肿瘤), TagDto(tagId=122723, tagName=哺乳期乳腺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5022, appHits=124, showAppHits=0, pcHits=378, showPcHits=4896, likes=0, shares=37, comments=7, approvalStatus=1, publishedTime=Thu Feb 10 15:24:00 CST 2022, publishedTimeString=2022-01-30, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Feb 09 21:30:33 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 10:12:45 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国妊娠期与哺乳期乳腺癌临床实践指南(2022版).pdf)])
中国妊娠期与哺乳期乳腺癌临床实践指南(2022版).pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1218011, encodeId=d7c4121801155, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/8UIXshhCxZdibxHcEvDTCdgXOnj4KibaUvgABfHffgqTuBdVyMr0ABAoUgzu9j5OsKqnZkVGPxGPuKVF1elNpoBg/132, createdBy=f4ea2383737, createdName=ms6205849327338719, createdTime=Mon May 09 08:44:18 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193952, encodeId=e152119395284, content=实用性强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee616470317, createdName=ms8000002131411968, createdTime=Wed Feb 16 10:49:42 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192741, encodeId=65531192e415b, content=非常好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 19:56:04 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192606, encodeId=12d0119260678, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/c172c9dac3194ed595ce61fa79e8fc21/5249297cae704c43b28d9f3fb461578c.jpg, createdBy=905e5401712, createdName=ms6000000229960255, createdTime=Sat Feb 12 10:07:09 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192278, encodeId=773111922e8f6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57b5438940, createdName=ms5000000321404738, createdTime=Fri Feb 11 12:13:13 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-05-09 ms6205849327338719

    非常感谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1218011, encodeId=d7c4121801155, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/8UIXshhCxZdibxHcEvDTCdgXOnj4KibaUvgABfHffgqTuBdVyMr0ABAoUgzu9j5OsKqnZkVGPxGPuKVF1elNpoBg/132, createdBy=f4ea2383737, createdName=ms6205849327338719, createdTime=Mon May 09 08:44:18 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193952, encodeId=e152119395284, content=实用性强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee616470317, createdName=ms8000002131411968, createdTime=Wed Feb 16 10:49:42 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192741, encodeId=65531192e415b, content=非常好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 19:56:04 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192606, encodeId=12d0119260678, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/c172c9dac3194ed595ce61fa79e8fc21/5249297cae704c43b28d9f3fb461578c.jpg, createdBy=905e5401712, createdName=ms6000000229960255, createdTime=Sat Feb 12 10:07:09 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192278, encodeId=773111922e8f6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57b5438940, createdName=ms5000000321404738, createdTime=Fri Feb 11 12:13:13 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-16 ms8000002131411968

    实用性强

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1218011, encodeId=d7c4121801155, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/8UIXshhCxZdibxHcEvDTCdgXOnj4KibaUvgABfHffgqTuBdVyMr0ABAoUgzu9j5OsKqnZkVGPxGPuKVF1elNpoBg/132, createdBy=f4ea2383737, createdName=ms6205849327338719, createdTime=Mon May 09 08:44:18 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193952, encodeId=e152119395284, content=实用性强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee616470317, createdName=ms8000002131411968, createdTime=Wed Feb 16 10:49:42 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192741, encodeId=65531192e415b, content=非常好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 19:56:04 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192606, encodeId=12d0119260678, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/c172c9dac3194ed595ce61fa79e8fc21/5249297cae704c43b28d9f3fb461578c.jpg, createdBy=905e5401712, createdName=ms6000000229960255, createdTime=Sat Feb 12 10:07:09 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192278, encodeId=773111922e8f6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57b5438940, createdName=ms5000000321404738, createdTime=Fri Feb 11 12:13:13 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-12 ms3000000637975859

    非常好,实用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1218011, encodeId=d7c4121801155, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/8UIXshhCxZdibxHcEvDTCdgXOnj4KibaUvgABfHffgqTuBdVyMr0ABAoUgzu9j5OsKqnZkVGPxGPuKVF1elNpoBg/132, createdBy=f4ea2383737, createdName=ms6205849327338719, createdTime=Mon May 09 08:44:18 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193952, encodeId=e152119395284, content=实用性强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee616470317, createdName=ms8000002131411968, createdTime=Wed Feb 16 10:49:42 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192741, encodeId=65531192e415b, content=非常好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 19:56:04 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192606, encodeId=12d0119260678, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/c172c9dac3194ed595ce61fa79e8fc21/5249297cae704c43b28d9f3fb461578c.jpg, createdBy=905e5401712, createdName=ms6000000229960255, createdTime=Sat Feb 12 10:07:09 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192278, encodeId=773111922e8f6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57b5438940, createdName=ms5000000321404738, createdTime=Fri Feb 11 12:13:13 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-12 ms6000000229960255

    谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1218011, encodeId=d7c4121801155, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/8UIXshhCxZdibxHcEvDTCdgXOnj4KibaUvgABfHffgqTuBdVyMr0ABAoUgzu9j5OsKqnZkVGPxGPuKVF1elNpoBg/132, createdBy=f4ea2383737, createdName=ms6205849327338719, createdTime=Mon May 09 08:44:18 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193952, encodeId=e152119395284, content=实用性强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee616470317, createdName=ms8000002131411968, createdTime=Wed Feb 16 10:49:42 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192741, encodeId=65531192e415b, content=非常好,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 19:56:04 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192606, encodeId=12d0119260678, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/c172c9dac3194ed595ce61fa79e8fc21/5249297cae704c43b28d9f3fb461578c.jpg, createdBy=905e5401712, createdName=ms6000000229960255, createdTime=Sat Feb 12 10:07:09 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192278, encodeId=773111922e8f6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57b5438940, createdName=ms5000000321404738, createdTime=Fri Feb 11 12:13:13 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-11 ms5000000321404738

    谢谢分享

    0